针对Mycobacterium tuberculosis 通过抑制三糖催化转移的持久性
Karishma Kalera1,2, Rachel Liu3, Juhyeon Lim3
1Department of Chemistry and Biochemistry, Central Michigan University, Mount Pleasant, Michigan 48859, United States.
ACS infectious diseases
|March 14, 2024
概括
研究人员鉴定出一种新型的三醇类似物,可以抑制Mycobacterium tuberculosis的持续形成. 这些化合物准了三醇的催化转移,为对抗耐药结核病感染提供了新的策略.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 结核病 (TB) 是由Mycobacterium tuberculosis (Mtb) 引起的,是主要的传染病杀手.
- 目前的结核病治疗需要一个充满挑战的六个月的抗生素治疗方案,因为Mtb的耐药性持续细胞.
- 持续形成的mtb依赖于三糖的催化转移,这是一个代谢适应.
研究的目的:
- 为了研究三醇的催化转移作为Mtb持续细胞的目标.
- 确定新型的三糖合成酶 (TreS) 抑制剂,并评估它们对MTB的疗效.
主要方法:
- 使用了生物膜持久模型,代谢学和冷电子显微镜 (cryo-EM).
- 合成并测试了化学酶的三醇类似物,包括2-三胺.
- 用基质模拟抑制剂确定了TresS的冷-EM结构.
主要成果:
- 阿齐多氧和阿米诺氧-d-三醇类似物通过抑制Tres.S.有效地阻断了Mtb三醇的催化转移.
- 在试验室和巨细胞模型中,2-三胺显示出高强度,并加强了现有的结核病药物.
- 化-EM结构揭示了TresS对催化和抑制剂结合的关键构造变化.
结论:
- 抑制三醇的催化转移是对抗Mtb持久性的有希望的策略.
- 特雷哈洛斯类似物,特别是2-特雷哈洛萨,显示出作为结核病辅助疗法的潜力.
- 对Tres的结构洞察力可以指导开发新的抗结核病疗法.
相关概念视频
Pulmonary Tuberculosis II
230
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
230
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242


